Sanofi | Pharma Commons 2012-05-31 09:28:58

In one of the worst kept secrets in the industry, Sanofi ($SNY) has been in the scrum of potential buyers forming around Amylin ($AMLN) in recent weeks. But even as the pharma giant's R&D chief hi…
Read the full story: News